Weight-loss drug approved for sleep apnea treatment in the US
⏺The FDA has granted approval for Zepbound, a drug designed to treat obstructive sleep apnea in adults with obesity. Already used for weight loss, Zepbound is the first medication of its kind to address the condition, which often requires CPAP machines.
⏺Clinical trials demonstrated that weekly doses of Zepbound significantly reduced apnea events compared to a placebo. Patients are advised to pair the treatment with a calorie-restricted diet and exercise.
INSIDER USA 👉🏻 Subscribe
⏺The FDA has granted approval for Zepbound, a drug designed to treat obstructive sleep apnea in adults with obesity. Already used for weight loss, Zepbound is the first medication of its kind to address the condition, which often requires CPAP machines.
⏺Clinical trials demonstrated that weekly doses of Zepbound significantly reduced apnea events compared to a placebo. Patients are advised to pair the treatment with a calorie-restricted diet and exercise.
INSIDER USA 👉🏻 Subscribe